Armitage P. (1995). Before and after Bradford Hill: Some trends in medical statistics. Journal of the Royal Statistical Society, 158, 143–153.
Armstrong D. (2002). Clinical autonomy, individual and collective: The problem of changing doctors' behaviour. Social Science & Medicine, 55, 1771–1777.
Ashcroft R. (2004). Current epistemological problems in evidence-based medicine. Journal of Medical Ethics, 30, 131–135.
Berg M. (1995). Turning a practice into a science: Reconceptualizing postwar medical practice. Social Studies of Science, 25, 437–476.
Chalmers I. (1990). Underreporting research is scientific misconduct. Journal of the American Medical Association, 263, 1405–1408.
Chalmers I., Hedges L., & Cooper H. (2002). A brief history of research synthesis. Evaluation & the Health Professions, 25, 12–37.
Cochrane A. (1972). Effectiveness and efficiency: Random reflections of health services. London: Nuffield Provincial Hospitals Trust.
Cochrane A. (1987). Cochrane in conversation with Max Blythe at Rhoose Farm, South Wales. Interview transcript, Medical Science Video Archive MSVA 024. Royal College of Physicians and Oxford Brookes University.
Corrigan O.P. (2002). ‘First in man’: The politics and ethics of women in clinical drug trials. Feminist Review, 72, 40–72.
Daly J., Willis K., Small R., Green J., Welch N., Kealy M. et al. (2006). A hierarchy of evidence for assessing qualitative health research. Journal of Clinical Epidemiology, 60, 43–49.
Dehue T. (2002). A Dutch treat: Randomized controlled experimentation and the case of heroin-maintenance in the Netherlands. History of the Human Sciences, 15, 75–98.
Doll R. (2003). Fisher and Bradford Hill: Their personal impact. International Journal of Epidemiology, 32, 929–931.
Goodman K.W. (2003). Ethics and evidence-based medicine. Cambridge: Cambridge UP.
Healy D. (2001). The dilemma posed by new and fashionable treatments. Advances in Psychiatric Treatment, 7, 322–327.
Jørgensen A.W., Hilden J., & Gøtzsche P.C. (2006). Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: Systematic review. British Medical Journal, 333, 782.
Kaptchuk T. (1998a). Intentional ignorance: A history of blind assessment and placebo controls in medicine. Bulletin of the History of Medicine, 72, 389–433.
Kaptchuk T. (1998b). Powerful placebo: The dark side of the randomised control trial. The Lancet, 351, 1722–1725.
Littlefield A.M. (1982). Ceteris paribus: The evolution of the clinical trial. Bulletin of the History of Medicine, spring, 1–18.
Marks H. (1997) The progress of experiment. Cambridge: Cambridge University Press.
May C. (2006). Mobilising modern facts: Health technology assessment and the politics of evidence. Sociology of Health and Illness, 28, 513–532.
Moncrieff J., & Cohen D. (2004). Rethinking models of psychotropic drug action. Psychotherapy and Psychosomatics, 970, 145–153.
Mykhalovskiy E., & Weir L. (2004). The problem of evidence-based medicine: Directions for social science. Social Science & Medicine, 59, 1059–1069.
Nguyen V.-K. (2005). Antitretroviral globalism, biopolitics and therapeutic citizenship. In Ong A., & Collier S.J. (Eds), Global assemblages: Technology, politics, and ethics as anthropological problems. Oxford: Blackwell.
Petryna A. (2005). Drug development and the ethics of the globalized clinical trial. Working Paper, School of Social Science (New School for Social Research), Princeton, NJ, October.
Rees W.L. (1997). The place of controlled trials in the development of psychopharmacology. History of Psychiatry, 8, 1–20.
Rose N. (1999). Governing the soul: The shaping of the private self. London: Free Association Books.
Sackett D. (1996). Evidence based medicine: What it is and what it isn’t. British Medical Journal, 312, 71–72.
Timmermans S., & Berg M. (2003). The gold standard: The challenge of evidence-based medicine and standardization in health care. Philadelphia, PA: Temple University Press.
Vandenbroucke J. (2002). The history of confounding. History of Epidemiology, 47, 216–224.